Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15807 articles
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
High histological grade (G3) predictor for higher pathological complete response in platinum-based therapy.
»
10/29/18
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth
Papillary areas appear to be both less proliferative and less necrotic.
»
10/26/18
Doctor, are you healthy? A cross-sectional investigation of oncologist burnout, depression, and anxiety and an investigation of their associated factors
Work-related stressors associated with burnout, but few associated with anxiety and depression.
»
10/26/18
Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI
Active treatment and diagnosis should be considered for iPCa patients with PSA >6.2 ng/ml.
»
11/01/18
Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles
Tetraspanin 1 found to be upregulated in plasma EVs from CC patients.
»
11/01/18
Glycoprotein-130 expression is associated with aggressive bladder cancer and is a potential therapeutic target.
Blocking GP130 has therapeutic potential in controlling tumor growth.
»
10/09/18
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.
Minimally invasive surgery associated with lower rate of disease-free survival.
»
11/01/18
Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort.
T2D predicted higher all-cause mortality (P
interaction.
»
09/07/18
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC).
Single-agent nab-paclitaxel associated with promising outcomes.
»
06/29/18
A meta-analysis of melanoma risk in industrial workers.
Slightly increased risk of developing melanoma among oil/petroleum industry workers.
»
10/30/18
< Prev
Next >